In addition to their effects on cancer signaling, HDACi engage the host immune system and upregulate or downregulate PD-L1 expression in different types of cancer cells [23, 24], which may be related to the nonspecific inhibitory effect of pan-HDACi and the diversity of HDAC enzyme in different tumors. This evidence concerns the gene CD274 and cancer.